Work

Enhancing proteotoxic stress as an anticancer strategy

Year: 2011

Type: article

Abstract: Steven Grant * Division of Hematology/Oncology, Department of Internal Medicine, Goodwin Research Laboratory, Richmond, VA Commentary on: Neznanov N, Komarov AP, Neznanova L, Stanhope-Baker P, Gudkov AV. Proteotoxic stress targeted therapy (PSTT): induction of protein misfolding enhances the antitumor effect of the proteasome inhibitor bortezomib. Oncotarget 2011;2(3):209-221 Received: April 27, 2011; Accepted: April 27, 2011; Published: April 27, 2011; Correspondence: Steven Grant, e-mail: // //

Source: Oncotarget

DOI: 10.18632/oncotarget.268

Author: Steven Grant

Language: English

Topic: Ubiquitin and proteasome pathways

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: hybrid

Funders: Multiple Myeloma Research Foundation, V Foundation for Cancer Research, Leukemia and Lymphoma Society, National Cancer Institute